Salopek T G, Slade J, Marghoob A A, Rigel D S, Kopf A W, Bart R S, Friedman R J
Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, USA.
J Am Acad Dermatol. 1995 Sep;33(3):441-50. doi: 10.1016/0190-9622(95)91390-4.
The incidence of malignant melanoma (MM) has rapidly increased during the past five decades. Relatively little information is available on whether the role of the dermatologist has increased concomitantly in the surgical management of this cancer.
Our purpose was to learn how members of the American Academy of Dermatology (AAD) treat patients with lesions highly suspected as being MM and how the management of these patients may have changed over the past decade. This, the first of a two-part series, concerns biopsies.
The data for the study were collected by means of a questionnaire that was sent to all members of the AAD practicing in the United States (N = 7412).
A total of 2991 valid questionnaires were returned, a response rate of 40%. The majority of respondents (89% in 1982; 90% in 1992) stated that they performed the biopsies of pigmented lesions suspected of being MMs. Excisional biopsy was the preferred technique (58% in 1982; 68% in 1992). The type of biopsy and who performed the initial biopsy of a suspected MM were associated with the following factors: (1) the number of years in practice, (2) the type of practice, and (3) whether the dermatologist subsequently performed the definitive surgery for the MM. Regional variations in biopsy practices were also noted.
Most AAD dermatologists who responded to the questionnaire perform the biopsies of lesions highly suspected of being MM. During the last decade an increasing proportion of dermatologists are performing excisional biopsies rather than other types of biopsies for such lesions.
在过去的五十年中,恶性黑色素瘤(MM)的发病率迅速上升。关于皮肤科医生在这种癌症的手术管理中的作用是否也随之增加,目前可获得的信息相对较少。
我们的目的是了解美国皮肤科协会(AAD)的成员如何治疗高度怀疑为MM的病变患者,以及在过去十年中这些患者的管理方式可能发生了哪些变化。这是一个两部分系列的第一部分,涉及活检。
该研究的数据通过向在美国执业的所有AAD成员(N = 7412)发送问卷的方式收集。
共返回了2991份有效问卷,回复率为40%。大多数受访者(1982年为89%;1992年为90%)表示他们对怀疑为MM的色素沉着病变进行活检。切除活检是首选技术(1982年为58%;1992年为68%)。活检类型以及谁对疑似MM进行初次活检与以下因素相关:(1)执业年限,(2)执业类型,以及(3)皮肤科医生随后是否对MM进行确定性手术。还注意到活检操作存在地区差异。
大多数回复问卷的AAD皮肤科医生对高度怀疑为MM的病变进行活检。在过去十年中,越来越多的皮肤科医生对这类病变进行切除活检,而非其他类型的活检。